Melbourne School of Engineering
The Melbourne School of Engineering (MSE) at the University of Melbourne has a well established international reputation for its research and teaching, as well as engagement with its community at large. The School boasts an incredibly talented pool of people that thrive on delivering outstanding research and education, and attracts some of the best and brightest students from around the globe. It is one of the largest providers of PhD education in the engineering and IT space in Australia, with well over 500 PhD students in training.
MSE is recognised for excellence in engineering and IT as may be gleaned from its position in world rankings such as published by The Times Higher Education. MSE’s research activities are focussed to benefit society in areas of global importance – biomedical engineering, information and communications, materials and sustainability. In order to tackle some of the global challenges in a meaningful way, MSE collaborates with leading national and international industry partners, medical research institutes and governmental agencies to construct meaningful partnerships that can deliver impact.
NICTA is Australia’s national research centre of excellence in Information and Communication Technology (ICT). NICTA’s Victoria Research Laboratory has world-class research expertise in Control and Signal Processing, ICT for Life Sciences and Health, optical and high-speed wireless communications, sensor networks, and is one of the largest ICT R&D centres in Victoria.
Recognising the increasing application of ICT in the Life Sciences to create new devices, processes, tools and products for improved prevention and care, the Victoria Research Laboratory in 2006 established highly collaborative research projects in the area of ICT for life sciences with the vision to create technology which contributes to the development and implementation of personalised medicine. The Laboratory is working with collaborators and partners to address a number of significant problems in personalised medicine:
- Bionic eye – the design and development of a retinal implant that will restore functional sight to people who suffer from Macular Degeneration, a major cause of blindness;
- Cancer genomics – the development of software tools to support genetic analysis.
- New generation Immunology – the development of computational biology and bio-image analytics to improve the understanding and processing of immunology data for the identification and treatment of disease.
- Pervasive biomedical devices for patient measurement and monitoring – for patients within clinics, hospitals and the community at large with current focus on motion analysis
- Biomedical data analytics – text mining technologies for medical researchers and clinicians.
Through its education program, NICTA is playing a key role in the education of upcoming generation of researchers applying ICT to life sciences problems.
The Bionics Institute
The Bionics Institute is an independent, not-for-profit medical research organisation specialising in the field of medical bionics. Medical Bionics is a multidisciplinary field of research combining bio(logy) and (electro)nics in order to develop implantable devices designed to provide sensory or motor function following damage to neural or muscle tissue. These devices have the potential to offer solutions to a wide range of debilitating conditions where other treatments are either unavailable or have been unsuccessful.
Based in Melbourne, the Institute has an international reputation for scientific rigour and research excellence. Bionic ear (cochlear implant) research began in the late 1960s at The University of Melbourne and the Bionic Ear Institute was established in 1986 by Professor Graeme Clark to ensure that research and development of this pioneering device continued.
In June 2011, under the directorship of Professor Rob Shepherd, we changed our name to the Bionics Institute to reflect fully the breadth of our research in three key areas:
Bionic Hearing. This research program aims to improve the performance of the cochlear implant and hearing aids, and enable their application to many more adults and children with hearing impairment. Specific projects include: research to enhance the perception of music and speech in noise; the development of techniques to promote the survival of the hearing nerve which slowly degenerates with deafness; and understanding how the brain responds to the long-term electrical stimulation provided by cochlear implants.
Bionic Vision. As part of the Bionic Vision Australia consortium of research institutions, we are developing a bionic eye to provide sight and independence to people with degenerative and genetic eye diseases. We are using our expertise in perception and engineering, as well as our experience in safety and biocompatibility studies, to establish safe surgical procedures and effective electrical stimulation strategies for the prototype bionic eye. The first clinical trials of this device are scheduled for 2013.
Neurobionics. The aim of this research is to develop implantable devices to detect, predict, and suppress abnormal brain activity. Over the next 5 years, we aim to develop a medical bionics platform – a flexible implantable device that can be used to treat a wide range of intractable conditions by tailoring the device to suit each application. These applications include drug-resistant epilepsy, motor disorders (e.g., Parkinson’s disease and essential tremor), and severe psychiatric disorders (e.g., obsessive-compulsive disorders).
The Institute focuses on the clinical applications of its innovative technology, as well as strong commercial outcomes that benefit people from all walks of life. We’re constantly seeking for new ways to improve medical bionics devices, and strengthen the Australian economy through innovation and training the next generation of researchers.
The Institute is accredited by the NHMRC as an administering institution and is formally affiliated with the University of Melbourne.
The Florey Neuroscience Institute
The Florey Neuroscience Institutes represents the Brain Research Institute, Howard Florey Institute and National Stroke Research Institute coming together as leaders in brain and mind research.
Florey Neuroscience Institutes employs approximately 500 people who collectively undertake world-class research into Stroke, Epilepsy, Multiple Sclerosis, Addiction, Depression, Brain & Spinal Cord Injury, Dementia and Parkinson’s Disease.
Phillips Ormonde Fitzpatrick
Phillips Ormonde Fitzpatrick provides strategic advice for technology companies at all stages of product development from early stage through to utilization and enforcement. Since its inception in 1888, the Phillips Ormonde & Fitzpatrick group has grown to incorporate a patent and trade mark attorney firm, a litigation firm and a research and investigation company which work together to provide a seamless and comprehensive service.
We provide a complete suite of intellectual property services from drafting patent applications and pursuing patent monopoly rights in Australia and overseas to patentability and freedom to operate searching, IP auditing, patent litigation and all kinds of intellectual property agreements including technology transfer, licensing and collaborative research agreements. With more than 45 patent attorneys and litigation specialists having technical qualifications and experience in diverse areas ranging from defence electronics and ICT to molecular and cell biology, physical sciences, chemistry and mining, Phillips Ormonde & Fitzpatrick meets the needs of clients with cutting edge technology emerging from a multi-disciplinary approach to innovation.
RMIT University is one of Australia’s original and leading educational institutions, producing some of Australia’s most employable graduates. As an innovative, global university of technology, with its heart in the city of Melbourne, RMIT has an international reputation for excellence in work-relevant education and high quality research, and engagement with the needs of industry and community.
With more than 70,000 students studying at RMIT campuses in Melbourne, in Vietnam, online, and at partner institutions throughout the world, the University is one of the largest in the country. It has built a worldwide reputation for excellence in professional and vocational education and research. A vibrant alumni community now stretches across more than 100 countries.
The College of Science, Engineering and Health has internationally-recognised expertise in a diverse range of disciplines and incorporates the fields of Sciences, Engineering, IT and Health and Medical Sciences. Comprising ten academic Schools (eight Higher Education schools and two TAFE schools), the College delivers a broad range of programs at apprenticeship, certificate, bachelor, masters and PhD levels. Many programs articulate between TAFE and Higher Education, creating pathways for further study.
The College is focused on providing practical solutions to real-life problems, developing and applying new knowledge and new ways of thinking about the environment and sustainability, health and wellbeing, and advanced technologies through education, research and projects, in collaboration with a wide range of partners. As an internationalised university of technology and design, RMIT brings unique capabilities and solutions to research through a trans-disciplinary approach that considers both the technological and social dimensions of the work at hand. Research at RMIT is particularly focused on solving the critical global problems affecting communities and the environment in the following areas: designing the future, smart technology solutions, sustainability and climate change challenges, and the future of cities. For information on current research see: www.rmit.edu.au/research
Bionic Vision Australia
Bionic Vision Australia (BVA) is an initiative of the Australian Research Council; a national consortium of researchers working together to develop a bionic eye.
The Australian bionic eye project brings together a cross-disciplinary group of world-leading experts in the fields of ophthalmology, biomedical engineering, electrical engineering, materials science, neuroscience, vision science, psychophysics, wireless integrated-circuit design, and surgical, preclinical and clinical practice.
The bionic eye project aims to restore a sense of vision to people living with blindness due to degenerative retinal conditions, such as retinitis pigmentosa and age-related macular degeneration. The bionic eye consists of a camera, attached to a pair of glasses, which captures the visual scene. This vision is processed externally and sent to an implant at the back of the eye, which stimulates cells in the retina with an electrode array. The impulses then pass down the optic nerve to the vision processing centres of the brain, where they are interpreted as an image.
BVA is concurrently developing two prototypes: the Wide-View and High-Acuity devices. The Wide-View device seeks to assist patients with orientation and mobility tasks, while the High-Acuity device aims to help patients recognise faces and read large print. Patient tests with the Wide-View device are scheduled to commence in 2013.
The BVA members are:
- The Centre for Eye Research Australia (CERA)
- The University of New South Wales (UNSW)
- The Bionics Institute
- The University of Melbourne
The University of Western Sydney, the National Vision Research Institute and the Royal Victorian Eye and Ear Hospital are supporting participants of the project.
The Victorian Life Sciences Computation Initiative (VLSCI) is providing a world-class high performance computing facility and research support, outreach and skills development services which are devoted to Computational Biology, Bioinformatics, and Computational Imaging. The Victorian Government has committed $50m to the project. It is hosted at The University of Melbourne and serves all Victorian Life Science researchers and their collaborators. The first IBM Research Collaboratory devoted to Life Sciences is co-located at VLSCI also. It joins a growing network of leading Victorian institutions which are developing life scientists of the future, attracting industry to Victoria and improving our health.
Monash University is committed to providing world-class research infrastructure to support our strong research community. Monash has a world-class integrated network of technology platforms in the areas of biomedicine, science and engineering. The equipment is state-of-the-art and the platform researchers and operators are internationally regarded as the best in the field. The Monash network of core technology research platforms provides a one-stop technology shop with strong governance, oversight and maintenance contracts ensure a seamless user experience. Monash University has developed many of these core technologies from schools and departments to make them more broadly available to our collaborating industry partners and to the wider research community. We are continuing to build a community of researchers who want to engage in the highest quality, innovative research.
Monash Biomedical Imaging (MBI) is a newly established biomedical imaging research facility that undertakes interdisciplinary and multi-modal imaging research in X-Ray, CT, PET, SPECT and MRI. The expertise and technological capabilities at MBI support a wide range of pre-clinical and clinical research projects undertaken by researchers and clinicians at Monash University and at our collaborating organisations. We have partnered with world-leading imaging technology providers, including Siemens and Agilent, to give our users access to the latest biomedical imaging technologies. MBI scientists are collaborating with global experts in medicine, science and engineering, as well as industry and government to create innovative solutions to clinical health challenges.
IBM is a global technology and innovation company that stands for progress. In 2011, IBM commemorates 100 years of innovation, bold risks and transformative breakthroughs. With operations in over 170 countries, IBMers invent and integrate hardware, software and services to help forward-thinking enterprises, institutions and people everywhere succeed in building a smarter planet. Working with government departments, Australian companies and equipping a legion of entrepreneurs, IBM makes a significant contribution to the Australian economy. Widely recognised as an employer of choice, IBM holds numerous awards for its industry-leading employment practices and policies.
IBM Research pushes the boundaries of science, technology and business to make the world work better. Our global network of scientists work in an open collaborative environment on a range of applied and exploratory research projects to help companies, governments and universities apply scientific breakthroughs to solve real-world business and societal challenges.
IBM Research and Development – Australia was established in October 2010. Located in close proximity to the University of Melbourne, the lab will grow to 150 technical and research staff over five years. Lab researchers are focused on the themes of Smarter Planet and Life Sciences. Within these areas, research projects in natural resources, disaster management and computational biology are being explored. The lab encompasses the IBM Research Collaboratory in Life Sciences – Melbourne, which is part of the Victorian Life Sciences Computation Initiative (VLSCI). Collaboratory researchers work with life sciences and medical researchers from the University of Melbourne and across Victoria, applying high performance computing to research problems in the biological sciences.
Melbourne Convention + Visitors Bureau (MCVB) is a not-for-profit organisation that assists academics, industry and local associations in bidding for and hosting international Conferences in Melbourne.
Home to 139 biotech companies, 13 major medical research institutes and nine universities, Melbourne is an international hub for innovation, research & development, and medicine and science.
MCVB provides assistance throughout the bidding process and the important time between a bid win and the Conference delivery. As we are supported by both the State Government and 270+ members, there is no fee for our services.
For more information contact (03) 9693 3333.
The Bio21 Cluster is a collaborative network of 22 research institutes, hospitals and universities that is both representative and emblematic of Victoria’s outstanding strengths in biomedical and biotechnology research.
The Bio21 Cluster facilitates collaborative projects, business development and educations programs to foster basic and translational research with the potential to solve major health problems and deliver social and economic benefits.
Activities of the Bio21 Cluster are based around four themes:
- Creating forums for developing ideas and collaborations
- Building collaborative resources and platform technologies
- Building capability via education and training
- Raising the profile of the Cluster, promoting the outcomes of its members and advocating with one voice on matters of importance to the health and biomedical sector in Australia
St Vincent’s Hospital
St Vincent’s Melbourne is a leading A1 tertiary hospital providing medical and surgical services, sub-acute care, aged care, correctional health care, mental health services and a range of community and outreach services. St Vincent’s is the largest metropolitan provider of hospital services to rural and regional Victoria and has an outstanding reputation in post graduate education and training. The hospital has a comprehensive research program involving basic and translational research. Additionally, bioengineering research leading to many successful clinical outcomes has been specifically fostered throughout the hospital’s research community in combination with associated Institutes co- located on the campus.
Melbourne Health is one of Victoria’s leading public healthcare services, with a strong tradition of providing the best possible care for our patients, excellent teaching and training for staff and future health professionals, and a commitment to biomedical research to improve outcomes for all. Serving a population base of more than
one million Melburnians, as well as regional and rural Victorians and interstate patients, our world-class reputation has its beginnings in The Royal Melbourne Hospital – Victoria’s first public hospital – established in 1848 to answer the need for public health services for a rapidly growing town.
Today, we are a partner in the internationally renowned Parkville Precinct, with our services involved in vibrant research programs turning biomedical research into clinical
improvements for our patients. Melbourne Health comprises The Royal Melbourne Hospital, North-Western Mental Health and the Victorian Infectious Diseases Reference Laboratory.
Melbourne Health at a glance:
• Almost 100,000 inpatient services in one year
• More than 645,000 outpatient appointments annually
• More than 57,000 emergency presentations each year
• More than 8,000 staff employed across 33 sites
• About 1,400 beds across hospital and community settings
• One of two major adult trauma services in Victoria
• More than 800 staff involved in clinical research across all disciplines
Centre for Neural Engineering
The CfNE is an interdisciplinary centre, forming part of the Melbourne Neuroscience Institute. Our aim is to tackle some of the great challenges in the neurosciences, and increase our understanding of neuronal and brain function.
Divided into four cutting-edge research laboratories, the CfNE will focus its research on: bionics, computational neurobiology, sensors and imaging, and stem cells and disease models.
Bionics – We aim to integrate electronic systems into the body to replace or assist their function by directly stimulating neurons. For example, the Bionic Ear is used to electrically stimulate the inner ear because the critical parts that pick up sound are no longer working. Our research is seeking to develop new systems and to improve the performance of existing bionic systems.
Computational Neurobiology – Bridging the gap from molecular structure to human behaviour. We will use novel approaches for collecting data at different spatial and temporal scales to develop multi-scale models that improve understanding of brain function in health and diseases.
The Stem Cells and Disease Models – we combine expertise in human stem cell biology, neurobiology, and cell and tissue engineering to study diseases of the human brain.
Sensors and Imaging – Understanding the dynamics of neuronal networks to gain insight into the brain’s information processing. By creating novel sensors of neural function, we can detect the electrical and chemical states of neurons and neural ensembles that can be exploited for the creation of novel drug therapies.
CSIRO, the Commonwealth Scientific and Industrial Research Organisation, is Australia’s national science agency and one of the largest and most diverse research agencies in the world with more than 6500 staff located across 56 sites throughout Australia and overseas.
CSIRO collaborates with many international partners on fundamental research and innovation for development. We also commercialise our technology and provide consulting and technical services to many countries. CSIRO is ranked in the top one per cent of world scientific institutions in 14 of 22 research fields.
Collaboration is also critical to CSIRO’s National Research Flagships which are large-scale multidisciplinary research partnerships that harness world-class expertise to tackle Australia’s most significant challenges and opportunities.
CSIRO’s expertise is organised into 14 research areas performed by the following Divisions, which are the business units of the organisation:
- Animal, Food and Health Sciences Energy Technology
- Livestock Industries
- Plant Industry
- Astronomy and Space Science
- Food & Nutritional Sciences
- Marine and Atmospheric Research
- Process Science and Engineering
- Earth Science and Resource Engineering
- ICT Centre
- Materials Science & Engineering
- Ecosystem Sciences
- Land and Water
- Mathematics, Informatics and Statistics
CSIRO also manages national facilities and collections that are opened to researchers around Australia and overseas.
As the home to Australia’s nuclear expertise, the Australian Nuclear Science
and Technology Organisation (ANSTO) is one of Australia’s largest research
Nuclear science and technology is a dynamic area of research that focuses on the
building blocks of matter. Many of the most important questions society faces in
areas such as health, climate change and industry are being investigated by ANSTO
At the heart of ANSTO’s research capabilities is the OPAL reactor which is one
of the world’s newest and best multi-purpose research reactors. OPAL is used for
scientific research, the production of medical radioisotopes, the activation of targets
and the irradiation of silicon used for electronics.
ANSTO LifeSciences addresses some of these large issues, working at the
molecular level using the unique capabilities of nuclear technologies to probe the
fundamental properties of living matter. Through collaborations and partnerships,
ANSTO LifeSciences addresses interdisciplinary research questions in health,
medicine, biology, agriculture, food and nutrition.
Using our expertise, capabilities and resources, ANSTO LifeSciences works to
reveal biological pathways and to improve prevention, diagnosis, and therapy
strategies for disease.
Find out more about us and how to collaborate with us at